FDA-Drug2019-08-14Class II
diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02
RXQ Compounding LLC
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide USA
Affected count
N/A
Manufactured in
340 W State St Unit 9, N/A, Athens, OH, United States
Products
diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1648-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief